Zio XT ECG Monitoring System vs VitalConnect VitalPatch

Direct competitors — feature-level head-to-head below. Comparability 88/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by VitalConnect

AI Verdict

Both tools are direct competitors in the wearable, AI-powered cardiac monitoring space, offering FDA-cleared and HIPAA-compliant solutions. Zio XT specializes in continuous single-lead ECG monitoring for arrhythmia detection and diagnosis over up to 14 days. In contrast, VitalPatch provides real-time streaming of up to 11 vital signs, including live ECG and 21 cardiac arrhythmias, for a 7-day period, catering to broader patient surveillance needs.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if your primary need is extended, comfortable, and highly compliant ambulatory cardiac monitoring for up to 14 days. This system is ideal for detecting intermittent arrhythmias where a longer monitoring period without real-time streaming of other vital signs is sufficient, leveraging its FDA-cleared AI and expert review for comprehensive diagnosis.

View Zio XT ECG Monitoring System →

Choose VitalConnect VitalPatch if…

Choose VitalConnect VitalPatch if you require real-time, continuous monitoring of multiple vital signs in addition to cardiac arrhythmias, for up to 7 days. This tool is best suited for scenarios where immediate insight into a broader range of physiological parameters, such as in critical care or remote patient monitoring requiring live data streams, is crucial.

View VitalConnect VitalPatch →

When choosing between the Zio XT ECG Monitoring System and the VitalConnect VitalPatch, physicians should consider the primary monitoring need and desired data granularity. The Zio XT system excels in extended, single-lead ECG monitoring for arrhythmia detection and diagnosis, offering up to 14 days of continuous wear with a focus on high patient compliance and a streamlined, lead-free design. Its FDA-cleared AI and expert review are specifically tailored for comprehensive cardiac event capture over a longer duration, making it ideal for identifying infrequent or paroxysmal arrhythmias.

In contrast, the VitalConnect VitalPatch provides real-time, continuous monitoring of a broader range of vital signs, including live ECG and detection of 21 cardiac arrhythmias, for up to 7 days. Its key practical difference lies in its ability to stream up to 11 vital signs in real-time, facilitated by patient-carried relay devices. This makes the VitalPatch particularly well-suited for situations requiring immediate, comprehensive physiological insights, such as in-hospital care or remote patient monitoring where a wider array of vital sign data beyond just ECG is critical. Physicians prioritizing extended, focused arrhythmia detection with high patient comfort should lean towards Zio XT, while those needing real-time, multi-parameter vital sign monitoring with robust arrhythmia detection for a shorter duration would find the VitalPatch more appropriate.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System VitalConnect VitalPatch
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. Cloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet).
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool A (Zio XT) offers a completely lead-free, water-resistant biosensor for up to 14 days of continuous monitoring, emphasizing enhanced patient comfort and achieving high patient compliance. Tool B, while also wearable and water-resistant, requires patient-carried relay devices, which may introduce additional complexity for the user compared to Tool A's self-contained system.

Clinical Value

VitalConnect VitalPatch

Tool B (VitalPatch) provides broader clinical value by offering real-time streaming of up to 11 vital signs, including live ECG, and detecting 21 cardiac arrhythmias. While Tool A excels in extended ECG monitoring for arrhythmia detection over 14 days, Tool B's comprehensive, real-time data stream is more versatile for immediate clinical decision-making across various care settings.

Pricing & Value

Zio XT ECG Monitoring System

Tool A (Zio XT) provides more transparent pricing details, including specific costs in the UK and proposed Medicare rates in the US. Tool B only states its pricing is subscription-based with monthly fees and is widely covered, lacking concrete figures for direct comparison.

Enterprise Readiness

Zio XT ECG Monitoring System

Both tools are cloud-based, FDA-cleared, and HIPAA compliant, indicating strong enterprise readiness. However, Tool A explicitly states 'no on-premise hardware required' and confirms BAA availability, offering a slightly clearer and potentially simpler deployment path for large organizations. Tool B's reliance on patient-carried relay devices might introduce minor logistical considerations.

Innovation

VitalConnect VitalPatch

Tool B (VitalPatch) demonstrates greater innovation by offering real-time streaming of a comprehensive suite of up to 11 vital signs alongside cardiac arrhythmia detection. While Tool A innovates with its extended 14-day wear time and high patient compliance for arrhythmia monitoring, Tool B's multi-parameter, real-time data capability represents a broader leap in continuous patient surveillance.

Support & Docs

Tie

Based on the provided structured facts, neither tool offers specific details regarding their support and documentation. Both companies are established in the medical device space and are expected to provide standard support resources, but without more specific comparative information, it is not possible to definitively distinguish between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System VitalConnect VitalPatch
Product Name Zio XT ECG Monitoring System VitalConnect VitalPatch
Company iRhythm Technologies VitalConnect
Monitoring Duration Up to 14 days of continuous cardiac monitoring 7-day (168-hour) continuous wear period per biosensor
ECG Lead Type Wearable single-lead ECG biosensor Live ECG
AI/Algorithm Use Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis Detection of 21 cardiac arrhythmias using AI algorithms
Key Monitored Parameters Continuous ambulatory cardiac monitoring (ECG) Real-time streaming of up to 11 vital signs, including live ECG; Detection of 21 cardiac arrhythmias

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and VitalConnect VitalPatch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio XT ECG Monitoring System provides continuous cardiac monitoring for up to 14 days. The VitalConnect VitalPatch offers a 7-day (168-hour) continuous wear period per biosensor.
The Zio XT ECG Monitoring System primarily focuses on single-lead ECG for arrhythmia detection. The VitalConnect VitalPatch can stream up to 11 vital signs in real-time, including live ECG.
The Zio XT ECG Monitoring System utilizes a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis and arrhythmia detection, complemented by expert review. The VitalConnect VitalPatch detects 21 cardiac arrhythmias using its AI algorithms.
The Zio XT biosensor is a wearable, single-lead ECG device with no external leads or wires, designed for up to 14 days of wear, is water-resistant, and reports high patient compliance and satisfaction. The VitalPatch is a water-resistant (IPX7) wearable biosensor with a medical-grade, hypoallergenic adhesive for 7-day continuous wear, but requires the patient to carry relay devices like a VistaPhone or VistaTablet.

Backers

Who funded each tool's parent company.

VitalConnect VitalPatch

AI Tool Finder
AI-powered search. Results may not be comprehensive.